Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

Value Health. 2014 Nov;17(7):A607-8. doi: 10.1016/j.jval.2014.08.2122. Epub 2014 Oct 26.

Authors

J Zigmond¹, L Pecen¹, A Tichopad¹, C S Roberts², I Jomaa³

Affiliations

¹ CEEOR s. r. o., Prague, Czech Republic.
² Pfizer Inc., New York, NY, USA.
³ Pfizer Pharmaceuticals Tunisia, Tunis, Tunisia.

PMID: 27202107
DOI: 10.1016/j.jval.2014.08.2122

No abstract available